Pulmonary lymphangitic carcinomatosis (PLC) is defined as infiltration of the lymphatic vessels and perilymphatic connective tissue with tumor cells, which is secondary to malignancy. Therefore, it rarely appears as an initial finding preceding a diagnosis of malignancy. A 30-year-old male patient was hospitalized in our clinic with a pre-diagnosis of interstitial lung disease owing to the complaints of dry cough, progressive dyspnea, and acute respiratory insufficiency. He was diagnosed with signet ring cell carcinoma, which is a histologic subtype of adenocarcinoma, via gastroscopy, and lung involvement was consistent with PLC. Regardless of the patient age, PLC should be considered in differential diagnoses of progressive dyspnea, acute respiratory failure, and widespread interstitial lung involvement. KEYWORDS:Progressive dyspnea, lymphangitic carcinomatosis, gastric cancer INTRODUCTIONPulmonary lymphangitic carcinomatosis (PLC) is the infiltration of pulmonary lymphatic vessels and connective tissue adjacent to these vessels by malignant cells. PLC comprises 6-8% of all lung metastases. The most common underlying tumors found are those of the breast, stomach, lung, prostate, and pancreas. Irrespective of the location of the primary tumor, the prognosis is worse [1].Involvement of the lymphatic vessels usually occurs following hematogenous seeding of the lungs. A less frequent mechanism is retrograde diffusion into the lymphatics of the mediastinal and hilar lymph nodes. Not only the central lymphatics consisting of the bronchovascular interstitium, but also the peripheral lymphatics consisting of the interlobular septa and beneath the pleura are involved. The radiologic features are similar to those of other interstitial lung diseases, which complicates a differential diagnosis. Thickening of bronchovascular bundles and interlobular septa, ground-glass opacity, pleural effusion, mediastinal lymphadenopathy, and nodular lesions are the common radiologic findings [2][3][4][5]. PLC may sometimes appear as the first finding before a diagnosis of tumor [6]. PLC is rarely reported as the first finding related to stomach tumor [7]. A 30-year-old male patient, who was diagnosed with signet cell gastric carcinoma after being admitted with PLC to the clinic and undergoing radiologic examination, is presented owing to his peculiar presentation. CASE PRESENTATIONA 30-year-old male patient presented to our outpatient clinic with complaints of shortness of breath, dry cough, weight loss, and night sweats. His complaints had started 2 months previously with a mild dry cough, which was progressive and had been accompanied by dyspnea during the previous 2 weeks. He had lost 5 kg in weight. His general condition was moderate, he had difficulty talking, and he had an oxygen saturation of 90% on finger probe. On chest X-ray, bilateral reticulonodular infiltration was noted (Figure 1a). He was hospitalized for detailed evaluation and treatment. He did not have any other medical diseases. He had a cigarette smoking history of 5 ...
astleman hastalığı (CH), anjiyofoliküler lenf nodu hiperplazisi olarak da bilinen ve seyrek görülen bir lenf nodu hastalığıdır. İlk kez 1954 yılında Castleman tarafından tanımlanmıştır.1 Hastaların %70'inden fazlasında toraks içinde mediasten veya hilusta yerleşmekle birlikte tüm vü-cutta da bulunabilmektedir. Etiyolojisi bilinmemektedir. Foliküler lenfoma, tüberküloz, sarkoidoz ve malign lezyonlar ayırıcı tanıda ön planda düşünülmesi gereken hastalıklardır. Kesin tanı için histopatolojik değerlendirme gereklidir.Bu çalışmada, kliniğimizde CH tanısı konulan olgu, literatür ışığı altında tartışılmıştır.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.